Mechanical activation of Efavirenz: the effects on the dissolution and inhibitory behavior

References

• Bitterlich A, Laabs C, Krautstrunk I, Dengler M, Juhnke M, Grandeury A, Bunjes H, Kwade A. 2015. Process parameter dependent growth phenomena of naproxen nanosuspension manufactured by wet media milling. Eur J Pharm Biopharm. 92:171–179.
   PubMed Web of Science ®Google Scholar
• Broseghini M, D’Incau M, Gelisio L, Pugno NM, Scardi P. 2017. Homogeneity of ball milled ceramic powders: effect of jar shape and milling conditions. Data in Brief. 10:186–191.
   PubMedGoogle Scholar
• Broseghini M, Gelisio L, D’Incau M, Azanza Ricardo CL, Pugno NM, Scardi P. 2016. Modeling of the planetary ball-milling process: the case study of ceramic powders. J Eur Ceram Soc. 36: 2205–2212.
   Web of Science ®Google Scholar
• Cappelletto E, Rebuffi L, Flor A, Scardi P. 2017. Microstructural effects of high-energy grinding on poorly soluble drugs: the case study of Efavirenz. Powder Diffr. 32(S1):S135–S140.
   Web of Science ®Google Scholar
• Chadha R, Arora P, Saini A, Jain DS. 2012. An insight into thermodynamic relationship between polymorphic forms of Efavirenz. J Pharm Pharm Sci. 15:234–251.
   PubMed Web of Science ®Google Scholar
• Chiappetta DA, Alvarez-Lorenzo C, Rey-Rico A, Taboada P, Concheiro A, Sosnik A. 2010. N-alkylation of poloxamines modulates micellar assembly and encapsulation and release of the antiretroviral efavirenz. Eur J Pharm Biopharm. 76:24–37.
   PubMed Web of Science ®Google Scholar
• Costa Pinto E, Cabral L, Pereira de Sousa V. 2014. Development of a discriminative intrinsic dissolution method for Efavirenz. Dissolution Technol. 21:31–40.
   Web of Science ®Google Scholar
• Fandaruff C, Segatto Silva MA, Galindo Bedor DC, Pereira de Santana D, Vinícius Antunes Rocha H, Rebuffi L, Azanza Ricardo CL, Scardi P, Cuffini SL. 2015. Correlation between microstructure and bioequivalence in anti-HIV drug Efavirenz. Eur J Pharm Biopharm. 91:52–58.
   PubMed Web of Science ®Google Scholar
• Fitriani L, Haqi A, Zaini E. 2016. Preparation and characterization of solid dispersion freeze-dried efavirenz - polyvinylpyrrolidone K-30. J Adv Pharm Technol Res. 7:105–109.
   PubMed Web of Science ®Google Scholar
• Kakran M, Li L, Muller RH. 2012. Overcoming the challenge of poor drug solubility. Pharma Eng. 32:1–7.
   Google Scholar
• Kalepu S, Nekkanti V. 2015. Insoluble drug delivery strategies: review of recent advances and business prospects. Acta Pharm Sin B. 5:442–453.
   PubMed Web of Science ®Google Scholar
• Khadka P, Ro J, Kim H, Kim I, Tae Kim J, Kim H, Cho JM, Yun G, Lee J. 2014. Pharmaceutical particle technologies: an approach to improve drug solubility, dissolution and bioavailability. Asian J Pharm Sci. 9:304–316.
   Google Scholar
• Klug HP, Alexander L. 1974. X-ray diffraction procedures: for polycrystalline and amorphous materials. 2nd ed. New York (NY): Wiley.
   Google Scholar
• Koyanagi Y, Miles S, Mitsuyasu RT, Merrill JE, Vinters HV, Chen IS. 1987. Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science. 236:819–822.
   PubMed Web of Science ®Google Scholar
• Leuner C, Dressman J. 2000. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm. 50: 47–60.
   PubMed Web of Science ®Google Scholar
• Liversidge GG, Cundy KC. 1995. Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs. Int J Pharm. 125:91–97.
   Web of Science ®Google Scholar
• Mosharraf M, Nystrom C. 1995. The effect of particle size and shape on the surface specific dissolution rate of microsized practically insoluble drugs. Int J Pharm. 122:35–47.
   Web of Science ®Google Scholar
• Muller RH, Keck CM. 2004. Challenges and solutions for the delivery of biotech drugs – a review of drug nanocrystal technology and lipid nanoparticles. J Biotechnol. 113:151–170.
   PubMed Web of Science ®Google Scholar
• Patel DJ, Patel JK, Pandya VM. 2010. Improvement in the dissolution of poorly water soluble drug using media milling technique. Thai J Pharm Sci. 34:155–164.
   Google Scholar
• Patel GV, Patel VB, Pathak A, Rajput SJ. 2013. Nanosuspension of efavirenz for improved oral bioavailability: formulation optimization, in vitro, in situ and in vivo evaluation. Drug Dev Ind Pharm. 40(1):80–91.
   PubMed Web of Science ®Google Scholar
• Rabinow BE. 2004. Nanosuspensions in drug delivery. Nat Rev Drug Discov. 3:785–796.
   PubMed Web of Science ®Google Scholar
• Raza K, Kumar P, Ratan S, Malik R, Arora S. 2014. Polymorphism: the phenomenon affecting the performance of drugs. SOJPPS. 1:1–10.
   Google Scholar
• Rebuffi L, Plaisier JR, Abdellatief M, Lausi A, Scardi P. 2014. MCX: a synchrotron radiation beamline form X-ray diffraction line profile analysis. Z Anorg Allg Chem. 640:3100–3106.
   Web of Science ®Google Scholar
• Reddy NP, Padmavathi Y, Mounika P, Anjali A. 2015. FTIR spectroscopy for estimation of efavirenz in raw material and tablet dosage form. Int Curr Pharm J. 4:390–395.
   Google Scholar
• Rosa A, Chande A, Ziglio S, De Sanctis V, Bertorelli R, Goh SL, McCauley SM, Nowosielska A, Antonarakis SE, Luban J, et al. 2015. HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation. Nature. 526:121–127.
   Web of Science ®Google Scholar
• Saleem IY, Smyth HDC. 2010. Micronization of a Soft Material: Air-Jet and Micro-Ball Milling. AAPS PharmSciTech. 11:1642–1649.
   PubMed Web of Science ®Google Scholar
• Santos Alves LD, Felts de La Roca Soares M, Tavares de Albuquerque C, Rodrigues da Silva E, Couto Carneiro Vieira A, Ferreira Fontes DA, Bezerra Melo Figueirêdo C, Soares Sobrinho JL, Rolim Neto PJ. 2014. Solid dispersion of efavirenz in PVP K-30 by conventional solvent and kneading methods. Carbohyd Polym. 104:166–174.
   PubMed Web of Science ®Google Scholar
• Sun J, Wang F, Sui Y, She Z, Zhai W, Wang C, Deng Y. 2012. Effect of particle size on solubility, dissolution rate, and oral bioavailability: evaluation using coenzyme Q10 as naked nanocrystals. Int J Nanomedicine. 7:5733–5744.
   PubMed Web of Science ®Google Scholar